BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Plaza-Díaz J, Solis-Urra P, Aragón-Vela J, Rodríguez-Rodríguez F, Olivares-Arancibia J, Álvarez-Mercado AI. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. Biomedicines 2021;9:145. [PMID: 33546191 DOI: 10.3390/biomedicines9020145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yan J, Nie Y, Liu Y, Li J, Wu L, Chen Z, He B. Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota. Front Cell Infect Microbiol 2022;12:824597. [DOI: 10.3389/fcimb.2022.824597] [Reference Citation Analysis]
2 Hong T, Chen Y, Li X, Lu Y. The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD. Oxid Med Cell Longev 2021;2021:6889533. [PMID: 34745420 DOI: 10.1155/2021/6889533] [Reference Citation Analysis]
3 . Diagnostic and prognostic potential of kallistatin in assessment of liver parenchyma changes in patients with non-alcoholic fatty liver disease and hypertension kallistatin in patients with NAFLD and hypertension. Imaging 2021;13:152-9. [DOI: 10.1556/1647.2021.00046] [Reference Citation Analysis]
4 Zhang B, Jiang M, Zhao J, Song Y, Du W, Shi J. The Mechanism Underlying the Influence of Indole-3-Propionic Acid: A Relevance to Metabolic Disorders. Front Endocrinol 2022;13:841703. [DOI: 10.3389/fendo.2022.841703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lim S, Kim JW, Targher G. Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metab 2021;32:500-14. [PMID: 33975804 DOI: 10.1016/j.tem.2021.04.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Anwar H, Iftikhar A, Muzaffar H, Almatroudi A, Allemailem KS, Navaid S, Saleem S, Khurshid M. Biodiversity of Gut Microbiota: Impact of Various Host and Environmental Factors. Biomed Res Int 2021;2021:5575245. [PMID: 34055983 DOI: 10.1155/2021/5575245] [Reference Citation Analysis]
7 Rueda-Robles A, Rubio-Tomás T, Plaza-Diaz J, Álvarez-Mercado AI. Impact of Dietary Patterns on H. pylori Infection and the Modulation of Microbiota to Counteract Its Effect. A Narrative Review. Pathogens 2021;10:875. [PMID: 34358024 DOI: 10.3390/pathogens10070875] [Reference Citation Analysis]
8 Li L, Huang Q, Yang L, Zhang R, Gao L, Han X, Ji L, Zou X. The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004. Nutrients 2022;14:1224. [PMID: 35334881 DOI: 10.3390/nu14061224] [Reference Citation Analysis]
9 Baumgartner S, Shiri-Sverdlov R. NASH and Systemic Complications: From Basic to Clinical Research. Biomedicines 2021;9:1913. [PMID: 34944726 DOI: 10.3390/biomedicines9121913] [Reference Citation Analysis]